[Korea Biomedical Review] Companies still working on natural extract-based Covid-19 drugs While Korean pharmaceutical and biotech companies have been slow to develop Covid-19 treatments, some continue developing Covid-19 dru...

[KOREA HERALD] S. Korea approves phase 2, 3 trials of Genencell’s COVID-19 treatment South Korean biotech firm Genencell said Wednesday that the company received approval from the Ministry of Food and Drug Safety for mid- an...

[Korea Biomedical Review] Regulator OKs Genencell’s P2, 3 trials for oral Covid-19 treatment Genencell said that the Ministry of Food and Drug Safety has approved the company’s investigational new drug (IND) application to c...

[Korea Biomedical Review] Genencell applies for late-stage clinical trials of plant-extracted Covid-19 therapy Genencell said Tuesday that it asked the Ministry of Food and Drug Safety to authorize phase 2 and 3 clinical tri...

[Korea Biomedical Review] Korean drugmakers race to develop natural extract-based Covid-19 drug in India Korean pharmaceutical and biotech companies are rushing to develop a Covid-19 treatment using natural ingredients. Aft...